The world has changed a lot in the 175 years since the founding of the University of Wisconsin. Some history-changing ideas that continue to reverberate around the globe got their start right here on the University of Wisconsin–Madison campus....
Experts say a wider diverse pool of patients needs to be given a chance to participate in clinical research to get rare disease drugs faster to market....
Enrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health’s Clinical Center in Bethesda, Maryland. ...
Cassandra Leopard discusses her career path and current role as Regulatory Supervisor for the UW Clinical Trials Institute (CTI)....
Being a clinical trial participant, especially in an interventional trial, is a sacrifice of time and body and represents a true commitment on the part of the patient....
Restrictive eligibility criteria has been a concern for many oncology researchers, who believe these trials should reflect a broader real-world population....
The UW School of Medicine and Public Health's Dr. Sterling Johnson recently joined Wisconsin Public Radio to discuss the Wisconsin Registry for Alzheimer's Prevention (WRAP) study at the University of Wisconsin-Madison....
Health-related discoveries in people can lead to better medical care for dogs. Likewise, studies of dog biology can lead to better understanding and treatments for people....
Are faster drug approvals by the FDA hurting the public's overall perception of clinical research?...
Commenters on the FDA's guidance on clinical investigations and drug development programs for psychedelic drugs raised concerns about decoupling drug administration from psychotherapy support, the proposed credentials for lead safety monitors and the agency’s characterization of the abuse potential of psychedelic drugs....
